• Citer

Mechanisms of hepatotoxicity caused by dacarbazine in rats

par Paschke, Ralf ;Heine, Michael;Braun, Sabine;Usadel, Klaus Henning
Référence Journal of cancer research and clinical oncology, 119, 8, page (475-481)
Publication Publié, 1993-08

Article révisé par les pairs

• Détails
• Contenu

Résumé :

Possible risks of fatal dacarbazine hepatotoxicity have not been studied systematically. We therefore asked whether dacarbazine hepatotoxicity is influenced by the dose or mode of application, by dacarbazine light-decay products, by prior liver damage or by an induction of dacarbazine metabolism. 22 Sprague-Dawley rats were treated with 4.5 mg and 200 mg dacarbazine/kg bodyweight i.p. and i.v., with dacarbazine light-decay products and with 4.5 mg and 200 mg dacarbazine/kg bodymass after previous galactosamine and ethanol treatment. Serum alanine amino-transferase, cholinesterase and white blood cell and platlet numbers were measured and liver histology was evaluated. Dose-dependent dacarbazine hepatotoxicity could be demonstrated by histology. The mode of application, dacarbazine light-decay products and acute liver damage did not influence dacarbazine hepatotoxicity. However 200 mg dacarbazine/kg bodymass after ethanol pretreatment caused significant serological changes and a significant leucodepression. The increased hepato-and myelotoxicity after induction of hepatic microsomal enzymes should be reason to exclude ethanol and drugs that induce hepatic microsomal enzymes prior to treatment with dacarbazine. © 1993 Springer-Verlag.